Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Saved in:
| Title: | Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. |
|---|---|
| Authors: | Stuver R; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Horwitz SM; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Advani RH; Stanford University, Stanford, California, USA., Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, USA., Lee HJ; MD Anderson Cancer Center, Houston, Texas, USA., Mehta-Shah N; Washington University in St. Louis, St. Louis, Missouri, USA., Zain JM; City of Hope, Duarte, California, USA., Haverkos B; University of Colorado, Boulder, Colorado, USA., Lechowicz MJ; Emory University, Atlanta, Georgia, USA., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Pham LQ; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA., Leyden E; University of Nebraska Medical Center, Omaha, Nebraska, USA., Ansell SM; Mayo Clinic, Rochester, Minnesota, USA., Lunning MA; University of Nebraska Medical Center, Omaha, Nebraska, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 525-529. Date of Electronic Publication: 2023 May 22. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37217196 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stuver+R%22">Stuver R</searchLink>; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.<br /><searchLink fieldCode="AU" term="%22Horwitz+SM%22">Horwitz SM</searchLink>; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.<br /><searchLink fieldCode="AU" term="%22Advani+RH%22">Advani RH</searchLink>; Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Vose+JM%22">Vose JM</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Lee+HJ%22">Lee HJ</searchLink>; MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Mehta-Shah+N%22">Mehta-Shah N</searchLink>; Washington University in St. Louis, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Zain+JM%22">Zain JM</searchLink>; City of Hope, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Haverkos+B%22">Haverkos B</searchLink>; University of Colorado, Boulder, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Lechowicz+MJ%22">Lechowicz MJ</searchLink>; Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Moskowitz+AJ%22">Moskowitz AJ</searchLink>; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.<br /><searchLink fieldCode="AU" term="%22Pham+LQ%22">Pham LQ</searchLink>; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Leyden+E%22">Leyden E</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Ansell+SM%22">Ansell SM</searchLink>; Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Lunning+MA%22">Lunning MA</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 525-529. <i>Date of Electronic Publication: </i>2023 May 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37217196 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.18885 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 525 Titles: – TitleFull: Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stuver R – PersonEntity: Name: NameFull: Horwitz SM – PersonEntity: Name: NameFull: Advani RH – PersonEntity: Name: NameFull: Vose JM – PersonEntity: Name: NameFull: Lee HJ – PersonEntity: Name: NameFull: Mehta-Shah N – PersonEntity: Name: NameFull: Zain JM – PersonEntity: Name: NameFull: Haverkos B – PersonEntity: Name: NameFull: Lechowicz MJ – PersonEntity: Name: NameFull: Moskowitz AJ – PersonEntity: Name: NameFull: Pham LQ – PersonEntity: Name: NameFull: Leyden E – PersonEntity: Name: NameFull: Ansell SM – PersonEntity: Name: NameFull: Lunning MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2023 Aug Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 202 – Type: issue Value: 3 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |